Data Científica
EL PODER DE LA CIENCIA Y LO NATURAL TRABAJANDO JUNTAS
Recorre en esta serie de contenidos de Cannabis de Esperanza, el vasto registro de las experiencias relacionadas con la ciencia y el progreso del universo medicinal cannábico. Estos contenidos se actualizan constantemente te sugerimos visitarlos y compartirlos.
Aceite Medicinal | ad campaign london | ad cannabis | ALL | ALPHA-PINENO | Anxiedad | Autocultivo | autocultivo peru | cancer | cancer de mama | cannabidiol (CBD) | Cannabis | Cannabis & Coronavirus | cannabis cultivation | cannabis dolor crónico | Cannabis Legal | Cannabis Medicinal | cannabis oncologico | Cannabis Peru | cannabis use decreases | CANNABIS WORLD JOURNAL | cann farm | cannfarm | cultivo asociativo Perú | demanda minsa | Dolor Cronico | dolor ortopédico crónico | Embarazo & Cannabis | Endocannabinoid system | Epilepsia | Esquizofrenia | Estudiantes | Farmacias | francesca brivio | goethe francesca brivio | goethe institute | Hablemos | hablemos claro | Insomnio | Investigación | Leucemia | londres campaña cannabis | Microdosis | nicolas lucar | Niños & Adolecentes | opioids | oxycodone | Pacientes | PARANOIA CANNABIS | Profesionales | programas cannabis pacientes | protesis cañamo | rural cannabis | sinergia | Sostenibilidad | teens dont smoke | tetrahydrocannabinol (THC) | uso adolescente | vec | veterinaria cannabica
Salud mental y calidad de vida en una población de usuarixs de cannabis medicinal en Brasil (TRADUCCIÓN)
Eficacia Percibida, Reducción en el Uso de Drogas Prescritas, y Efectos Secundarios Mínimos de Cannabis en Pacientes con Dolor Ortopédico Crónico
Síndrome de hiperémesis cannabinoide: Encuesta e investigación genómica (Redacción)
Estudio halla que manejar en cannabis medicinal no es más riesgoso que manejar en otra medicación prescrita (TRADUCCIÓN)
Cuidado para Síntomas Conductuales de la Demencia (CBD): Una Nueva Investigación hacia el Cannabidiol para el Tratamiento de la Agitación y la Demencia en Enfermedad de Alzheimer
The relationships between marijuana use and exercise among young and middle-aged adults
Cannabis y autismo: una dupla compleja (TRADUCCIÓN)
Cannabinoides y mastocitosis (guía completa)
Rate of Second Primary Head and Neck Cancer With Cannabis Use
A Survey on the Effect That Medical Cannabis Has on Prescription Opioid Medication Usage for the Treatment of Chronic Pain at Three Medical Cannabis Practice Sites
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol
Cannabinoides, oído interno, escucha y tinnitus: una perspectiva neuroinmunológica
Experiencia de migraña, su severidad y eficacia de tratamientos percibida entre usuarios cannábicos
The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas
In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas
The impact of naturalistic cannabis use on self-reported opioid withdrawal
Beneficial Effects of Cannabis on Blood Brain Barrier Function in HIV
Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study
A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health
Medicinal Cannabis Effective for Chronic Insomnia in Clinical Trial
Cannabis para dolor neuropático en adultos
Potencial analgésico de los cannabinoides
An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care.
An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care.
Duration of abstinence from cannabis is positively associated with verbal learning performance: A systematic review and meta-analysis.
Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based investigation.
Association of Marijuana Laws With Teen Marijuana Use
The Association of Unfavorable Traffic Events and Cannabis Usage: A Meta-Analysis
Association Between Marijuana Use and Sexual Frequency in the United States: A Population-Based Study
Crash Fatality Rates After Recreational Marijuana Legalization in Washington and Colorado
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.
Cannabinoids and the Microbiota-Gut-Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders.
Variability of baseline vehicle control among sober young adult cannabis users: A simulator-based exploratory study
A Pilot Study of a Medical Cannabis – Opioid Reduction Program
Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes
Associations between adolescent cannabis use frequency and adult brain structure: A prospective study of boys followed to adulthood
Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in multiple rodent models of nicotine dependence
Opportunities for cannabis in supportive care in cancer
The heterogeneity and complexity of Cannabis extracts as antitumor agents
Safety and Efficacy of Medical Cannabis in Fibromyalgia
Medical Cannabis
The Impact of Cannabis Consumption on Mortality, Morbidity, and Cost in Acute Pancreatitis Patients in the United States: A 10-Year Analysis of the National Inpatient Sample.
Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions.
A quasi-experimental evaluation of marijuana policies and youth marijuana use
Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders
Cannabis sativa L. Micropropagation in Temporary Immersion Bioreactor System
Previous Use of Alcohol, Cigarettes, and Marijuana and Subsequent Abuse of Prescription Opioids in Young Adults
Reduction of Benzodiazepine Use in Patients Prescribed Medical Cannabis
Medical Cannabis Users’ Comparisons between Medical Cannabis and Mainstream Medicine.
Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence.
Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
Cannabidiol in Anxiety and Sleep: A Large Case Series.
Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat.
Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults
Content of illicit cannabis extracts used to treat children with epilepsy revealed
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1.
Cannabinoids in health and disease.
Cannabinoids in intestinal inflammation and cancer.
Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines.
Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.
Cannabinoid receptors as novel targets for the treatment of melanoma.
[Different views on the association between cannabinoids and cancer].
Cannabinoids and gliomas.
Pharmacokinetics and pharmacodynamics of cannabinoids.
Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.
Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism.
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma
Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.
Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.
Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma.
Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines.
Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells.
Antitumorigenic effects of cannabinoids beyond apoptosis.
A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells.
Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis.
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.
Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors.
Cannabinoids as potential new therapy for the treatment of gliomas.
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells.
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.
The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi’s sarcoma cells in vitro.
Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism.
The endocannabinoid anandamide neither impairs in vitro T-cell function nor induces regulatory T-cell generation.
Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders.
Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells.
Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein.
De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis.
Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis.
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.
Cannabinoids and ceramide: two lipids acting hand-by-hand.
Control of the cell survival/death decision by cannabinoids.
Effects on cell viability.
Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway.
Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.
Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis.
Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1.
A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells.
The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration.
Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers?
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death.
High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells.
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo.
Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells.
p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells.
Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway.
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor.
Cannabinoids and cancer.
[The endocannabinoid system as a target for the development of new drugs for cancer therapy].
Cannabinoids in the treatment of cancer.
Cannabinoids and cell fate.
Cannabinoid receptor ligands as potential anticancer agents–high hopes for new therapies?
Cannabinoids for cancer treatment: progress and promise.
Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.
Inhibition of tumor angiogenesis by cannabinoids.
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.
Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.
Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism.
Cannabinoid receptor as a novel target for the treatment of prostate cancer.
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications
Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1.
Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.
Cannabinoids inhibit cellular respiration of human oral cancer cells.
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
Cannabis-derived substances in cancer therapy–an emerging anti-inflammatory role for the cannabinoids.
Cannabis and Cannabinoids (PDQ®)–Health Professional Version
Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor.
Cannabinoid receptors in human astroglial tumors.
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review).
Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.
Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation.
The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway.
The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.
Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas.
Cannabinoids and gliomas.
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.
Involvement of cannabinoids in cellular proliferation.
Hypothesis: cannabinoid therapy for the treatment of gliomas?
Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans.
Cannabinoid receptor systems: therapeutic targets for tumour intervention.
In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas.
The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas.
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism
Does the legalization of medical marijuana increase completed suicide?
Medical cannabis and mental health: A guided systematic review
The Clinical Significance of Endocannabinoids in Endometriosis Pain Management
Endocannabinoid involvement in endometriosis
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
Clinical Trial: Plant-Derived CBD/THC Extracts Safe And Effective For Children With Intractable Epilepsy
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia
Content of illicit cannabis extracts used to treat children with epilepsy revealed
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.
WHO Expert Committee on Drug Dependence Critical Review: Cannabidiol (CBD) Expert Peer Review 2
WHO Expert Committee on Drug Dependence Critical Review: Cannabidiol (CBD) Expert Peer Review 1
CANNABIDIOL (CBD) Critical Review Report
WHO Expert Committee on Drug Dependence Pre – Review Cannabis plant and cannabis resin Section 4: Therapeutic use
WHO Expert Committee on Drug Dependence Pre – Review Cannabis plant and cannabis resin Section 3: Toxicology
WHO Expert Committee on Drug Dependence Pre – Review Cannabis plant and resin Section 2: Pharmacology
WHO Expert Committee on Drug Dependence Pre – Review Cannabis plant and cannabis resin Section 1: Chemistry
WHO Expert Committee on Drug Dependence Pre-Review: Cannabis plant and resin Expert Peer Review 2
WHO Expert Committee on Drug Dependence Pre – Review: Cannabis plant and resin Expert Peer Review 1
WHO Expert Committee on Drug Dependence Pre-Review Cannabis plant and cannabis resin Section 5: Epidemiology
Actualización sobre el potencial terapéutico de los cannabinoides
Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases.
Medical Oncologists’ Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study.
Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis.
Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents – An observational, longitudinal study.
Effect profile of paracetamol, Δ9‐THC and promethazine using an evoked pain test battery in healthy subjects
A naturalistic examination of the perceived effects of cannabis on negative affect.
La legalización del cannabis con fines terapéuticos no ha incrementado su consumo en adolescentes
El consumo de cannabis se asocia con menor prescripción de opioides en pacientes con VIH
El consumo de cannabis protege contra la enfermedad hepática alcohólica
El uso médico del cannabis mejora el rendimiento cognitivo
Cannabis for the Management of Cancer Symptoms: THC Version 2.0?
Acute Effects of Smoked Marijuana and Oral Δ9-Tetrahydrocannabinol on Specific Airway Conductance in Asthmatic Subjects
Bronchial Effects of Aerosolized Δ9-Tetrahydrocannabinol in Healthy and Asthmatic Subjects
Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors.
Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens.
The Impact of Δ9-THC on the Psychological Symptoms of Anorexia Nervosa: A Pilot Study.
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer.
Bronchial Effects of Aerosolized Δ9-Tetrahydrocannabinol in Healthy and Asthmatic Subjects
Natural Remedies for Treatment of Cancer Pain
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke.
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization.
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex
Anticancer mechanisms of cannabinoids.
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns
Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons.
Single dose delta‐9‐tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability
Single dose delta‐9‐tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
Cannabis – the Israeli perspective
Endocannabinoids and Cancer
OWC Pharmaceutical Research Announces the Promising Results of Phase Lab Testing for Multiple Myeloma
Cannabis in cancer care.
Handbook of Cannabis
Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy.
Dronabinol treatment of refractory nausea and vomiting related to peritoneal carcinomatosis.
Information for Health Care Professionals
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data
A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.
EL PODER DE LO NATURAL SE COMPARTE
COMPARTE NUESTRO CONTENIDO CON LOS QUE MAS QUIERES